-
Mashup Score: 34
Complement 3 glomerulopathy (C3G) presents complex diagnostic hurdles due to its rarity, clinical heterogeneity, and lack of definitive biomarkers. Tune in to hear Dr. Gates Colbert and Dr. Anuja Java discuss the need for improved biomarker development, our evolving understanding of complement dysregulation, and the importance of multidisciplinary awareness in advancing timely and accurate diagnosis. Dr. Java is an Associate Professor of Medicine in the Division of Nephrology at Washington University School of Medicine and the Director of the Kidney Transplant Clinic at John Cochran Veterans Hospital in Missouri.
Source: reachmd.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 22OBGYN - 1 month(s) ago
Objective The objective of the study was to investigate the role of genetic variants in complement proteins in pre-eclampsia. Design In a case–control study involving 609 cases and 2092 controls, …
Source: obgyn.onlinelibrary.wiley.comCategories: General Medicine News, NephrologyTweet-
🙏@asnpublications for this editorial on our collaborative work with FINNPEC group investigating the role of complement in preeclampsia!! This is part 2 of the following series. More to come https://t.co/C4kV5GvCAn https://t.co/O6BO0vtJLu @silvishah @kdjhaveri @gudnephron https://t.co/4WKH7mMv4p
-
-
Mashup Score: 4Thrombotic Microangiopathy and the Kidney - 2 month(s) ago
Thrombotic microangiopathy (TMA) is a clinical syndrome characterized by endothelial injury and thrombotic occlusion of the microvasculature, leading to end-organ damage. This systemic disorder can affect any organ system, including the brain, heart, and gastrointestinal tract. However, the kidney is the most frequently affected organ.[1]
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, NephrologyTweet-
RT @aHUSAllianceAct: Thrombotic Microangiopathy and the Kidney: #StatPearls, updated 4 March 2025 https://t.co/IzXQIOOuJQ Don't miss the h…
-
-
Mashup Score: 13How the MDIBL Renal Fellows Course influenced my career trajectory - 2 month(s) ago
Author: Anuja Java, MD Dr. Anuja Java during water homeostasis module I am a proud MDIBL alumnus, and memories of my time and experience there are amo
Source: www.renalfellow.orgCategories: General Medicine News, NephrologyTweet-
Just saw this pop up when searching for a citation 🤩 Truly one of my most treasured memories from fellowship yrs @MDIBL Thank you @RenalFellowNtwk for the opportunity to share this ♥️. @Nephro_Sparks #MarkZeidel #WilliamJeffrey #SYadlapalli https://t.co/Q5udm7ZOeW
-
-
Mashup Score: 24
Point of Care – Clinical decision support for Thrombotic Microangiopathy and the Kidney. Treatment and management. Introduction, Etiology, Epidemiology, Pathophysiology, Histopathology, History and Physical, Evaluation, Treatment / Management, Differential Diagnosis, Prognosis, Complications, Deterrence and Patient Education, Enhancing Healthcare Team Outcomes
Source: www.statpearls.comCategories: General Medicine News, NephrologyTweet-
Congratulations @kidneymo and prior @WashUNephrology fellow @AbdullahJalalMD for this write-up on TMAs for @StatPearls1 Provides a streamlined summary in a compact and accessible format!! https://t.co/GABjiBJovJ
-
-
Mashup Score: 2Identification of complement factor H variants that predispose to pre-eclampsia: A genetic and functional study - PubMed - 6 month(s) ago
These results suggest that complement dysregulation due to mutations in complement factor H is among the pathophysiological mechanisms underlying severe pre-eclampsia.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, NephrologyTweet-
The first in the series was published last year: https://t.co/v4IKYqdCEn
-
-
Mashup Score: 35Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia - 6 month(s) ago
Genes & Immunity – Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia
Source: www.nature.comCategories: General Medicine News, NephrologyTweet-
Sequel of our collaborative work on the role of complement in preeclampsia is out: https://t.co/O6BO0vtJLu
-
-
Mashup Score: 202024 Mid-Career Women Faculty Leadership Development Seminar - 7 month(s) ago
I’m attending the AAMC’s 2024 Mid-Career Women Faculty Leadership Development Seminar! I’m looking forward to connecting with other women faculty, enhancing my leadership capabilities, and creating an actionable plan for my career progression. Check out the program.
Source: web.cvent.comCategories: General Medicine News, NephrologyTweet-
Attending the @AAMCtoday 2024 Mid-Career Women Faculty Leadership Development Seminar with @LeslieGewin @WashUNephrology Connecting with 176 women faculty from around the country has been empowering!! 🙏@WashUDeptMed for support! https://t.co/PgFEzyMxtq ##LDatAAMC https://t.co/KR3LxAa0F1
-
-
Mashup Score: 21Advancing IgAN Care: Exploring the Next Wave of Treatments - 7 month(s) ago
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
Source: www.hcplive.comCategories: General Medicine News, NephrologyTweet-
Discussing IgAN @HCPLiveNews from basic pathophysiology to new developments with a fabulous crew @SWadhwaniMD @brendonneuen @md_ellie, led by the master @IgAN_JBarratt 🤩 Is it normal to cringe at your own voice in recordings ☹️🙈?? https://t.co/a31dSEj2AM
-
-
Mashup Score: 51Establishing the Future Direction of Clinical Outcomes in C3 Glomerulopathy: Perspectives From a Patient and a Physician - 7 month(s) ago
Complement 3 glomerulopathy (C3G) is an ultra-rare glomerulonephritis caused by dysregulation of the alternative complement pathway. C3G has an estimated incidence of 1–3 cases per million people in the United States. Diagnosing C3G based solely on clinical and laboratory features is challenging since it mimics several other glomerular diseases; therefore, diagnosis requires a kidney biopsy. In the absence of disease-modifying therapies and optimal patient management strategies, C3G poses a significant physical and emotional burden on patients and caregivers.
Source: www.kidneymedicinejournal.orgCategories: General Medicine News, NephrologyTweet-
Just published!! This one is special since my co-author was my 1st #C3G pt as a fellow 10+ yrs ago 😊 Lindsey’s story highlights many important aspects of the disease!!! Thanks @KidneyMed for prioritizing this. https://t.co/gctnR5wLM6
-
I recently joined @DoctorGates for two mini episodes on #C3G, where we discussed diagnostic challenges & emerging treatments. Grateful for the opportunity to contribute to the conversation & share what we’re learning!! https://t.co/HuwgGlEwVj https://t.co/JyKCoSgQTk